These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1466350)

  • 1. Routine lipid profile in patients with and without restenosis after percutaneous transluminal coronary angioplasty.
    Schumacher M; Eber B; Toplak H; Klein W
    Am J Cardiol; 1992 Dec; 70(20):1640. PubMed ID: 1466350
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl.
    Dzavik V; Teo KK; Yokoyama S; Modi R; Dinwoodie A; Burton JR; Tymchak WJ; Montague TJ
    Am J Cardiol; 1995 May; 75(14):936-8. PubMed ID: 7733005
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of neopterin as a marker for restenosis following percutaneous transluminal coronary angioplasty.
    Eber B; Schumacher M; Tatzber F; Kaufmann P; Luha O; Esterbauer H; Gasser R; Klein W
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):361-2. PubMed ID: 7662605
    [No Abstract]   [Full Text] [Related]  

  • 4. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis after percutaneous transluminal coronary angioplasty.
    Pedersen HK; Vatne K; Simonsen S
    Acta Radiol; 1992 Mar; 33(2):149-51. PubMed ID: 1562409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty.
    Chenu PC; Schroeder E; Krémer R; Marchandise B
    Am J Cardiol; 1993 Nov; 72(15):1209-11. PubMed ID: 8237819
    [No Abstract]   [Full Text] [Related]  

  • 8. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
    Jorgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Høstmark AT; Thaulow E
    Eur Heart J; 1999 Oct; 20(19):1407-14. PubMed ID: 10487801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Restenosis after percutaneous transluminal coronary angioplasty].
    Haze K
    Kokyu To Junkan; 1989 Dec; 37(12):1283-93. PubMed ID: 2616905
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoprotein (a) is not a risk factor for restenosis after percutaneous transluminal coronary angioplasty.
    Schumacher M; Tiran A; Eber B; Toplak H; Wilders-Truschnig M; Klein W
    Am J Cardiol; 1992 Feb; 69(5):572. PubMed ID: 1531283
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography.
    Schumacher M; Eber B; Tiran A; Toplak H; Luha O; Gasser R; Klein W
    Cardiology; 1992; 80(5-6):345-8. PubMed ID: 1451121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary stenting for the treatment of restenosis after percutaneous transluminal coronary angioplasty.
    Haude M; Erbel R
    J Interv Cardiol; 1994 Aug; 7(4):341-6. PubMed ID: 10151065
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Take S; Matsutani M; Ueda H; Hamaguchi H; Konishi H; Baba Y; Kawaratani H; Sugiura T; Iwasaka T; Inada M
    Am J Cardiol; 1997 Apr; 79(8):1097-9. PubMed ID: 9114771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty.
    Abbate R; Marcucci R; Camacho-Vanegas O; Pepe G; Gori AM; Capanni M; Simonetti I; Prisco D; Gensini GF
    Am J Cardiol; 1998 Aug; 82(4):524-5. PubMed ID: 9723646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serum lipid levels on restenosis after coronary angioplasty.
    Reis GJ; Kuntz RE; Silverman DI; Pasternak RC
    Am J Cardiol; 1991 Dec; 68(15):1431-5. PubMed ID: 1746423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group.
    Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A
    Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recanalization of chronic coronary artery occlusions using laser followed by balloon angioplasty.
    Schofer J; Kresser J; Rau T; Kunze KP; Kühn CR; Mathey DG
    Am J Cardiol; 1996 Oct; 78(7):836-8. PubMed ID: 8857495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty.
    Carlsson J; Miketic S; Mueller KH; Brom J; Ross R; von Essen R; Tebbe U
    Lancet; 1997 Oct; 350(9086):1225. PubMed ID: 9652570
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise echocardiography performed early and late after percutaneous transluminal coronary angioplasty for prediction of restenosis.
    Hoffmann R; Lethen H; Flachskampf FA; Hanrath P
    Eur Heart J; 1995 Dec; 16(12):1872-9. PubMed ID: 8682020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.